The molecular mechanisms that lead to glaucoma are not well established but are of significant biomedical interest given that glaucoma is a leading cause of blindness worldwide, and early-onset myocilin glaucoma accounts for ∼4% of glaucoma cases, primarily afflicting children [1]. This evidence concerns the gene MYOC and glaucoma.